CERO THERAPEUTICS HOLDINGS, INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
CERO THERAPEUTICS HOLDINGS, INC. (CERO) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $5.54 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-04-15
- CERO THERAPEUTICS HOLDINGS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $5.54M.
- CERO THERAPEUTICS HOLDINGS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $4.04M.
- CERO THERAPEUTICS HOLDINGS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $0.00.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 7 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 11 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 11 month as first filed | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|---|---|---|
| 2025-12-31 | $5.54M 10-K · filed 2026-04-15 | |||
| 2024-12-31 | $4.04M 10-K · filed 2026-04-15 | $4.43M 10-K · filed 2025-04-15 | ||
| 2023-12-31 | $4.04M 10-K · filed 2025-04-15 | |||
| 2022-12-31 | $0.00 10-K · filed 2023-03-24 | |||
| 2021-12-31 | -$52.94K 10-K · filed 2023-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |